Jenni M. Vuola

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

Samuel McConkey, William H. H. Reece, Vasee Moorthy et al. · Nature Medicine · 2003 · 557 citations · Full text

Vaccination, Vaccine Development, Immunology +8

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

Daniel P. Webster, Susanna Dunachie, Jenni M. Vuola et al. · Proceedings of the National Academy of Sciences · 2005 · 244 citations · Full text

Malaria, Immunology, Recombinant Poxviruses Fp9 +16

High Rates of Clinical and Subclinical Tuberculosis among HIV-Infected Ambulatory Subjects in Tanzania

Lillian Mtei, Mecky Matee, Oliver Herfort et al. · Clinical Infectious Diseases · 2005 · 187 citations · Full text

Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers

Jenni M. Vuola, Sheila M. Keating, Daniel P. Webster et al. · The Journal of Immunology · 2005 · 154 citations

Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria

Sheila M. Keating, Philip Bejon, Tamara Berthoud et al. · The Journal of Immunology · 2005 · 125 citations · Full text

Vaccination, Autoimmune Disease, Vaccine Development +15